Application of tofacitinib in treatment of seven patients with anti-MDA5 autoantibody-positive dermatomyositis-associated with interstitial lung disease and literature review
1Department of Rheumatology and Immunology, the First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
2Department of Rheumatology and Immunology, the First Hospital of Yulin, Yulin, Shaanxi 719000, China
3Department of Rheumatology and Immunology, Hainan Hospital of Chinese PLA General Hospital, Sanya, Hainan 572013, China
收起